Omega-3 Index: Normal Range, Interpretation and How to Improve It
Most people taking fish oil do not know whether it is actually working. The level of omega-3 in the body cannot be assessed by how you feel. The Omega-3 Index solves exactly this problem: it objectively measures how much EPA and DHA is incorporated into red blood cell membranes — an objective marker of omega-3 status throughout the body. Its interpretation is straightforward: the normal Omega-3 Index in most adults is 4–6%, but the target to improve cardiovascular and brain outcomes is 8–12%.
What Is the Omega-3 Index and How Is It Measured?
The Omega-3 Index is the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell membrane fatty acids.
Formula: Omega-3 Index = (EPA + DHA) / total fatty acids × 100%
Why red blood cells? Their lifespan is 90–120 days, so the fatty acid composition of their membrane reflects mean omega-3 intake over that period — analogous to how HbA1c reflects mean blood glucose over three months.
The assay uses whole blood (not plasma): venous blood is drawn, red blood cells are isolated, and fatty acid profiling is performed by chromatography.
Omega-3 Index Normal Ranges
| Category | Value | Risk |
|---|---|---|
| Deficient | < 4% | High cardiovascular risk |
| Low | 4–6% | Elevated risk |
| Target | 8–12% | Optimal protection |
| Excess | > 12% | No proven harm, rare |
Most Western adults fall in the 4–6% range. The target of 8% was established by researcher William Harris, who developed the Omega-3 Index concept. Below 4% is the high-risk zone, particularly for cardiac outcomes.
Omega-3 and Heart Health
The omega-3 — cardiovascular disease relationship is among the most studied in nutritional science.
Anti-arrhythmic effect. DHA stabilises the electrical conductance of cardiomyocytes. The REDUCE-IT trial (2018) showed that 4 g of EPA daily reduced major cardiovascular events by 25% in patients with hypertriglyceridaemia. Cohort data show that an index above 8% is associated with a 90% lower risk of sudden cardiac death compared with an index below 4%.
Triglyceride reduction. EPA and DHA lower hepatic triglyceride synthesis and circulating triglyceride levels by 20–30%. This is directly linked to C-reactive protein — the inflammatory marker.
Endothelial effects. Omega-3 fatty acids improve vascular wall elasticity, reduce platelet adhesion and lower inflammatory cytokines.
Omega-3, the Brain and Cognitive Function
DHA is the principal structural component of neuronal membranes. The adult brain contains about 20 g of DHA; grey matter is 15–20% DHA by mass.
DHA deficiency is associated with memory impairment, depression and increased Alzheimer's disease risk. Prospective studies show that individuals with a high Omega-3 Index have larger hippocampal volumes and slower age-related cognitive decline.
EPA influences neuroinflammation by suppressing arachidonic acid synthesis and reducing central nervous system inflammation. For those tracking biological age markers, the Omega-3 Index is an essential component — see omega-3 index and longevity.
Why Omega-3 Supplements May Not Work
Not all fish oil forms are equally bioavailable.
Form matters. The triglyceride form (natural fish oil) is absorbed approximately 70% better than ethyl esters (most cheap capsules). The phospholipid form (krill oil) has the highest bioavailability but lower EPA+DHA content by weight.
Fat co-ingestion is essential. Omega-3 fatty acids are fat-soluble. Taking them on an empty stomach reduces bioavailability two to threefold. Always take with a meal containing fat.
Dose. Raising the index to 8% requires approximately 2–3 g of EPA+DHA daily (not grams of fish oil — check the label for EPA+DHA specifically). A standard "1000 mg fish oil capsule" contains only about 300 mg of EPA+DHA — seven to ten times less than needed.
Oxidation. Fish oil oxidises on contact with oxygen. Rancid oil is not only ineffective but potentially harmful. A reliable marker: fish burps immediately after taking the capsule indicate oxidation. Quality oil is odourless and tasteless.
How to Get an Omega-3 Index Test and Improve Your Level
The test requires whole blood drawn from a vein; no special fasting preparation is needed. Re-test after 3–4 months of changing dose or form: this is how long it takes for the erythrocyte pool to fully turn over, giving an accurate reflection of the intervention.
A comprehensive nutritional status assessment also includes vitamin D and C-reactive protein — together these three provide a picture of anti-inflammatory capacity. See the vitamin panel for a full nutritional screen.
Frequently Asked Questions
The Omega-3 Index measures EPA+DHA in red blood cell membranes — a stable marker reflecting saturation over 90–120 days, analogous to HbA1c for blood glucose. Plasma omega-3 is an unstable snapshot of the past few hours of intake. For assessing long-term omega-3 status, only the Omega-3 Index is clinically meaningful.
The target is 8–12%. Below 4% carries substantially elevated cardiovascular risk. Most adults in continental Europe and North America fall in the 4–6% range due to low fatty fish consumption and inadequate supplement dosing. Values above 12% are rare and carry no proven adverse effects.
Only if the dose and form are correct. A standard 1000 mg fish oil capsule provides about 300 mg of EPA+DHA — against a required 2–3 g daily. Use the triglyceride or phospholipid form, take with a fat-containing meal, and check the label for the combined EPA+DHA figure rather than total oil weight. Retest after 3–4 months to confirm effect.
Wild salmon (1.5–2 g per 100 g), mackerel (2–2.5 g), herring (1.5–2 g), sardines (1–1.5 g) and anchovies (1–1.5 g) are the richest sources. Two to three portions of fatty fish per week provide roughly 2 g of EPA+DHA daily. Plant-based omega-3 sources (flaxseed, walnuts) contain ALA, which converts to EPA/DHA at only 5–15% efficiency — they do not raise the Omega-3 Index reliably.
Yes — that is precisely when testing is most useful. Many people take omega-3 supplements and assume their levels are fine, while their index remains at 4–5%. The test shows whether a specific product at a specific dose is working. Without testing, supplementation is guesswork. Retest every 6–12 months while supplementing.
Yes, the association is documented. DHA is a structural component of neuronal membranes; EPA influences neuroinflammation. Meta-analyses show that EPA+DHA supplementation reduces depressive symptoms, particularly in mild to moderate depression. The effect is strongest when baseline C-reactive protein is not markedly elevated — meaning systemic inflammation is not the primary driver.
Upload your lab results photo or PDF
AI explains your results in 30 seconds
Choose fileRate the service
Your feedback helps us improve the service